rs372962551
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000426.4(LAMA2):c.3175-32_3175-31delGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,371,902 control chromosomes in the GnomAD database, including 10,107 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 1235 hom., cov: 31)
Exomes 𝑓: 0.10 ( 8872 hom. )
Consequence
LAMA2
NM_000426.4 intron
NM_000426.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0980
Publications
2 publications found
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 6-129312825-TTG-T is Benign according to our data. Variant chr6-129312825-TTG-T is described in ClinVar as Benign. ClinVar VariationId is 256066.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.377 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | c.3175-35_3175-34delTG | intron_variant | Intron 22 of 64 | 5 | NM_000426.4 | ENSP00000400365.2 | |||
| LAMA2 | ENST00000618192.5 | c.3439-35_3439-34delTG | intron_variant | Intron 23 of 65 | 5 | ENSP00000480802.2 | ||||
| LAMA2 | ENST00000617695.5 | c.3175-35_3175-34delTG | intron_variant | Intron 22 of 63 | 5 | ENSP00000481744.2 |
Frequencies
GnomAD3 genomes AF: 0.106 AC: 16165AN: 152080Hom.: 1233 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
16165
AN:
152080
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.135 AC: 33557AN: 247754 AF XY: 0.128 show subpopulations
GnomAD2 exomes
AF:
AC:
33557
AN:
247754
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.102 AC: 124733AN: 1219704Hom.: 8872 AF XY: 0.101 AC XY: 62622AN XY: 619320 show subpopulations
GnomAD4 exome
AF:
AC:
124733
AN:
1219704
Hom.:
AF XY:
AC XY:
62622
AN XY:
619320
show subpopulations
African (AFR)
AF:
AC:
2250
AN:
28676
American (AMR)
AF:
AC:
11742
AN:
44132
Ashkenazi Jewish (ASJ)
AF:
AC:
2400
AN:
24538
East Asian (EAS)
AF:
AC:
14881
AN:
38586
South Asian (SAS)
AF:
AC:
7752
AN:
81218
European-Finnish (FIN)
AF:
AC:
6624
AN:
53244
Middle Eastern (MID)
AF:
AC:
644
AN:
5308
European-Non Finnish (NFE)
AF:
AC:
72586
AN:
891780
Other (OTH)
AF:
AC:
5854
AN:
52222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
5835
11670
17506
23341
29176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2728
5456
8184
10912
13640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.106 AC: 16172AN: 152198Hom.: 1235 Cov.: 31 AF XY: 0.112 AC XY: 8301AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
16172
AN:
152198
Hom.:
Cov.:
31
AF XY:
AC XY:
8301
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
3232
AN:
41536
American (AMR)
AF:
AC:
3103
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
332
AN:
3472
East Asian (EAS)
AF:
AC:
2013
AN:
5152
South Asian (SAS)
AF:
AC:
499
AN:
4824
European-Finnish (FIN)
AF:
AC:
1246
AN:
10590
Middle Eastern (MID)
AF:
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5406
AN:
68012
Other (OTH)
AF:
AC:
234
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
705
1409
2114
2818
3523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
682
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
May 27, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Oct 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.